Key result
A pharmacist-led, protocol-driven clinic for patients with diabetic nephropathy significantly reduced systolic blood pressure from 151 to 133 mmHg (P<0.001).
Why the study?
Does a pharmacist-led, protocol-driven clinic improve blood pressure, cholesterol, and albuminuria in patients with diabetic nephropathy?
Observational (n=116)
Does a pharmacist-led, protocol-driven clinic improve blood pressure, cholesterol, and albuminuria in patients with diabetic nephropathy?
Absolute Event Rate: 133% vs 151%
p-value: p=<0.001
A pharmacist-led, protocol-driven clinic significantly improves blood pressure, cholesterol, and albuminuria in patients with diabetic nephropathy.
May support pharmacist-led BP management in diabetic nephropathy; hypothesis-generating, needs RCTs before practice change.
Intensive multifactorial intervention reduces end points in patients with diabetic nephropathy. Traditional clinics struggle to provide the intensity of care required to meet targets for this growing patient group. We designed a pharmacist-led, protocol driven clinic to offer stepwise intensive treatment to patients with diabetic nephropathy picked up at the traditional secondary care clinic. One hundred and sixteen individuals received more than one review. The clinic achieved significant improvements in blood pressure (BP): systolic 151±19 mmHg vs.133±15 mmHg (p<0.001), diastolic 80±10 mmHg vs. 68±10 mmHg (p<0.001) and total cholesterol 4.56 mmol/L±1.05 mmol/L vs. 4.03±1.07 mmol/L (p<0.001). Albumin:creatinine ratio also improved 27±44 vs. 20±31 (p=0.02). Structured intervention within a pharmacist-led clinic has led to a rapid and significant reduction in BP and cholesterol in microalbuminuric patients. This format of care can form the basis of patient focused, target driven, care.
No takes yet. Share an insight, caveat, or question.
Kelly et al. (2008) conducted an observational in Diabetic nephropathy (n=116). Pharmacist-led, protocol-driven clinic vs. Baseline (pre-intervention) was evaluated on Systolic blood pressure (p=<0.001). A pharmacist-led, protocol-driven clinic for patients with diabetic nephropathy significantly reduced systolic blood pressure from 151 to 133 mmHg (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: